These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27111610)

  • 1. Synthetic biology tackles global antivenom shortage.
    Arnold C
    Nature; 2016 Apr; 532(7599):292. PubMed ID: 27111610
    [No Abstract]   [Full Text] [Related]  

  • 2. New techniques in antivenom production and active immunization against snake venoms.
    Theakston RD
    Trans R Soc Trop Med Hyg; 1989; 83(4):433-5. PubMed ID: 2694474
    [No Abstract]   [Full Text] [Related]  

  • 3. IgG subclass distributions of anti-horse serum antibodies and natural venom-antibodies produced in response to antivenom injection or snake bite in humans.
    Ameno S; Ameno K; Fuke C; Kiryu T; Ijiri I
    Toxicon; 1990; 28(3):347-50. PubMed ID: 2343468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Avidity of sera-neutralizing snake venom].
    Abidov AA; Lisochenko LG; Zaidova SM
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Feb; (2):115-8. PubMed ID: 665016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new Pan African polyspecific antivenom developed in response to the antivenom crisis in Africa.
    Laing GD; Renjifo JM; Ruiz F; Harrison RA; Nasidi A; Gutierrez JM; Rowley PD; Warrell DA; Theakston RD
    Toxicon; 2003 Jul; 42(1):35-41. PubMed ID: 12893059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Snake antivenom: Challenges and alternate approaches.
    Alangode A; Rajan K; Nair BG
    Biochem Pharmacol; 2020 Nov; 181():114135. PubMed ID: 32628928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of antivenoms in the treatment of snake envenomation].
    Chippaux JP
    Bull Acad Natl Med; 2013; 197(4-5):993-1006; discussion 1006-8. PubMed ID: 25518165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of health status of horses immunized with snake venom and montanide adjuvants, IMS 3012 (nanoparticle), ISA 206 and ISA 35 (emulsion based) during polyvalent snake antivenom production: hematological and biochemical assessment.
    Waghmare AB; Salvi NC; Deopurkar RL; Shenoy PA; Sonpetkar JM
    Toxicon; 2014 May; 82():83-92. PubMed ID: 24582735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS; Wanas S; Helmy MH; Hashem M
    J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time for an alternative perspective: the eternal problem of supply and quality of anti snake venom in the developing world--"it's the economy, stupid".
    Simpson ID
    Wilderness Environ Med; 2008; 19(3):186-94. PubMed ID: 18715131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: Novel Immunotherapies Against Envenomings by Snakes and Other Venomous Animals.
    Laustsen AH; Ainsworth S; Lomonte B; Kini RM; Chávez-Olórtegui C
    Front Immunol; 2020; 11():1004. PubMed ID: 32670269
    [No Abstract]   [Full Text] [Related]  

  • 12. Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa.
    Gutiérrez JM; Rojas E; Quesada L; León G; Núñez J; Laing GD; Sasa M; Renjifo JM; Nasidi A; Warrell DA; Theakston RD; Rojas G
    Trans R Soc Trop Med Hyg; 2005 Jun; 99(6):468-75. PubMed ID: 15837359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the method of determining the effect of antimyonecrotic factor antibody in Habu-antivenin [proceedings].
    Chinzei H
    Jpn J Med Sci Biol; 1978 Apr; 31(2):204-5. PubMed ID: 682381
    [No Abstract]   [Full Text] [Related]  

  • 14. Vipers, mambas and taipans: the escalating health crisis over snakebites.
    Arnold C
    Nature; 2016 Sep; 537(7618):26-8. PubMed ID: 27582205
    [No Abstract]   [Full Text] [Related]  

  • 15. Antisnake venom production crisis--who told us it was uneconomic and unsustainable?
    Simpson ID; Jacobsen IM
    Wilderness Environ Med; 2009; 20(2):144-55. PubMed ID: 19594208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human heterophilic antibodies against equine immunoglobulins: assessment of their role in the early adverse reactions to antivenom administration.
    León G; Segura A; Herrera M; Otero R; França FO; Barbaro KC; Cardoso JL; Wen FH; de Medeiros CR; Prado JC; Malaque CM; Lomonte B; Gutiérrez JM
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1115-9. PubMed ID: 18561967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response towards snake venoms.
    León G; Sánchez L; Hernández A; Villalta M; Herrera M; Segura A; Estrada R; Gutiérrez JM
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):381-98. PubMed ID: 21824081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti snake venom crisis in Africa: a suggested manufacturers product guide.
    Simpson ID; Blaylock RS
    Wilderness Environ Med; 2009; 20(3):275-82. PubMed ID: 19737031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In Africa snake venom antivenins in short supply. Fatal risk for foreign tourists?].
    Mebs D
    MMW Fortschr Med; 2002 Sep; 144(37):57. PubMed ID: 12380345
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hematologic values and serum enzymes in horses inoculated with snake venoms for the production of antivenins in Costa Rica].
    Estrada R; Chaves F; Robles A; Rojas E; Segura E; Gutiérrez JM
    Rev Biol Trop; 1992 Apr; 40(1):95-9. PubMed ID: 1297173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.